Others have demonstrated a role in inducing statin-induced apoptosis resistance, increasing the invasive and metastatic potential of tumor cells [9], and a direct interaction between the SH2 domain of CTEN and MET, which reduces its endocytosis and increases cell survival potential [16]. The gene discussed is MET; the disease is neoplasm.